Recherche
Résultats 11-20 de 46
-
Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP).
Bone Marrow Transplantation, 25-09-2022, 57, 1803–1809Article dans une revue scientifique -
An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT.
Bone Marrow Transplantation, 11-05-2023Article dans une revue scientifique -
Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP study.
Bone Marrow Transplantation, 27-11-2023Article dans une revue scientifique -
The first steps towards a diverse and inclusive EBMT: a position paper.
Bone Marrow Transplantation, 07-02-2022, 57, 343–346Article dans une revue scientifiquetexte intégral -
Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients-The DIADEM study from the chronic malignancies working party of the EBMT.
Bone Marrow Transplantation, 23-01-2023Article dans une revue scientifique -
A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease.
Bone Marrow Transplantation, 12-06-2021Article dans une revue scientifiquetexte intégral -
Compatibility at amino acid position 98 of micb reduces the incidence of graft-versus-host disease in conjunction with the cmv status
Bone Marrow Transplantation, 07-2020, 55, 1367–1378Article dans une revue scientifiquetexte intégral -
Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf sfgm-tc and fim groups
Bone Marrow Transplantation, 08-2021, 56, 1888–1899Article dans une revue scientifique -
Thiotepa-busulfan-fludarabine (tbf) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the chronic malignancies working party of the ebmt
Bone Marrow Transplantation, 01-02-2021, 56, 1593–1602Article dans une revue scientifique -
Haemophagocytic lymphohistiocytosis following allogeneic hematopoietic cell transplantation from mismatched unrelated donors associated with low cd34 and cd3 cell counts in the graft
Bone Marrow Transplantation, 04-2022, 57, 658–660Article dans une revue scientifique